GL1X · GenesisL1 explorer

Research workbench

Crystal structure of frac with lipids

Analyse Crystal structure of frac with lipids in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4TSY
Type
protein
Length
704 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fragaceatoxin C
UniProt
B9W5G6
Ligands
HXJ, HTO, SO4
Pockets
8 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DFragaceatoxin Cprotein17618% helix, 46% strandB9W5G6

Ligands and binding sites

  • HXJ · 2-[[(E,2S,3R)-2-(hexanoylamino)-3-oxidanyl-dec-4-enoxy]-oxidanyl-phosphoryl]oxyethyl-trimethyl-azanium · ligand · 12 copies · chains A, B, C, D
  • HTO · Heptane-1,2,3-triol · ligand · chains A
  • SO4 · Sulfate ion · ion · 19 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11970.460.7528HXJ
22040.460.7431HXJ
31920.450.7430HXJ
4660.350.7716HXJ
5680.340.7616HXJ

Interfaces

3 interfaces between chains.

  • C–D · 818 Ų buried · 10 hydrogen bonds · protein-protein
  • B–C · 799 Ų buried · 11 hydrogen bonds · protein-protein
  • A–B · 798 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 4TSY · Crystal structure of FraC with lipids · the same entry in another collection · chain D against D, TM-score 1.00
  • B9W5G6 · AlphaFold monomer V2.0 prediction for delta-actitoxin-AFR1A (B9W5G6) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.